These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 15556137

  • 1. Pharmacological characterization of rebamipide: its cholecystokinin CCK1 receptor binding profile and effects on Ca2+ mobilization and amylase release in rat pancreatic acinar cells.
    Moon SJ, An JM, Kim J, Lee SI, Ahn W, Kim KH, Seo JT.
    Eur J Pharmacol; 2004 Nov 28; 505(1-3):61-6. PubMed ID: 15556137
    [Abstract] [Full Text] [Related]

  • 2. A novel effect of rebamipide: generation of [Ca(2+)](i) oscillations through activation of CCK(1) receptors in rat pancreatic acinar cells.
    Moon SJ, Ahn W, Lee MG, Kim H, Lee SI, Seo JT, Case RM, Kim KH.
    Eur J Pharmacol; 2000 Jan 24; 388(1):17-20. PubMed ID: 10657542
    [Abstract] [Full Text] [Related]

  • 3. Cholecystokinin peptides stimulate pancreatic secretion by multiple signal transduction pathways.
    Yoshida H, Tsunoda Y, Owyang C.
    Am J Physiol; 1997 Sep 24; 273(3 Pt 1):G735-47. PubMed ID: 9316479
    [Abstract] [Full Text] [Related]

  • 4. Two functionally distinct cholecystokinin receptors show different modes of action on Ca2+ mobilization and phospholipid hydrolysis in isolated rat pancreatic acini. Studies using a new cholecystokinin analog, JMV-180.
    Matozaki T, Göke B, Tsunoda Y, Rodriguez M, Martinez J, Williams JA.
    J Biol Chem; 1990 Apr 15; 265(11):6247-54. PubMed ID: 1690723
    [Abstract] [Full Text] [Related]

  • 5. High-affinity cholecystokinin type A receptor/cytosolic phospholipase A2 pathways mediate Ca2+ oscillations via a positive feedback regulation by calmodulin kinase in pancreatic acini.
    Lankisch TO, Nozu F, Owyang C, Tsunoda Y.
    Eur J Cell Biol; 1999 Sep 15; 78(9):632-41. PubMed ID: 10535305
    [Abstract] [Full Text] [Related]

  • 6. Intracellular control of IP3-independent Ca2+ oscillations in pancreatic acini.
    Tsunoda Y, Yoshida H, Owyang C.
    Biochem Biophys Res Commun; 1996 May 15; 222(2):265-72. PubMed ID: 8670194
    [Abstract] [Full Text] [Related]

  • 7. Involvement of RhoA and its interaction with protein kinase C and Src in CCK-stimulated pancreatic acini.
    Nozu F, Tsunoda Y, Ibitayo AI, Bitar KN, Owyang C.
    Am J Physiol; 1999 Apr 15; 276(4):G915-23. PubMed ID: 10198335
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. U73122 inhibits Ca2+ oscillations in response to cholecystokinin and carbachol but not to JMV-180 in rat pancreatic acinar cells.
    Yule DI, Williams JA.
    J Biol Chem; 1992 Jul 15; 267(20):13830-5. PubMed ID: 1629184
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
    Povoski SP, Zhou W, Longnecker DS, Bell RH.
    Oncol Res; 1994 Jul 15; 6(9):411-7. PubMed ID: 7703527
    [Abstract] [Full Text] [Related]

  • 14. Cholecystokinin-JMV-180 and pilocarpine are potent inhibitors of cholecystokinin and carbachol actions on guinea pig pancreatic acinar cells.
    Sjödin L, Viitanen E, Gylfe E.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May 15; 355(5):631-7. PubMed ID: 9151303
    [Abstract] [Full Text] [Related]

  • 15. Cholecystokinin-8s excites identified rat pancreatic-projecting vagal motoneurons.
    Wan S, Coleman FH, Travagli RA.
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug 15; 293(2):G484-92. PubMed ID: 17569742
    [Abstract] [Full Text] [Related]

  • 16. CCK antagonists reveal that CCK-8 and JMV-180 interact with different sites on the rat pancreatic acinar cell CCKA receptor.
    Yule DI, Williams JA.
    Peptides; 1994 Aug 15; 15(6):1045-51. PubMed ID: 7527529
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies.
    Bignon E, Bachy A, Boigegrain R, Brodin R, Cottineau M, Gully D, Herbert JM, Keane P, Labie C, Molimard JC, Olliero D, Oury-Donat F, Petereau C, Prabonnaud V, Rockstroh MP, Schaeffer P, Servant O, Thurneyssen O, Soubrié P, Pascal M, Maffrand JP, Le Fur G.
    J Pharmacol Exp Ther; 1999 May 15; 289(2):742-51. PubMed ID: 10215648
    [Abstract] [Full Text] [Related]

  • 19. Receptor occupation, calcium mobilization, and amylase release in pancreatic acini: effect of CCK-JMV-180.
    Sato S, Stark HA, Martinez J, Beaven MA, Jensen RT, Gardner JD.
    Am J Physiol; 1989 Aug 15; 257(2 Pt 1):G202-9. PubMed ID: 2475030
    [Abstract] [Full Text] [Related]

  • 20. Pharmacologic profile of TS-941, a new benzodiazepine derivative cholecystokinin-receptor antagonist, in in vitro isolated rat pancreatic acini.
    Tashiro M, Hirohata Y, Kihara Y, Akiyama T, Otsuki M.
    Pancreas; 1999 Mar 15; 18(2):156-64. PubMed ID: 10090413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.